Clinical Trial Update: A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes the termination of a Phase 2/3 study sponsored by Allergan evaluating a new treatment for non-infectious anterior uveitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Uveitis

Snippet

Sponsor: Allergan | Conditions: Anterior Uveitis | Phase 2, Phase 3 | Status: TERMINATED